维立志博机会点：临床_老虎社区_美港股上老虎

维立志博机会点：临床数据背书+TEC赛道的稀缺性，这两个应该够用了

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":452941295161656,"tweetId":"452941295161656","gmtCreate":1751607193819,"gmtModify":1752717069857,"author":{"id":4209696716609150,"idStr":"4209696716609150","authorId":4209696716609150,"authorIdStr":"4209696716609150","name":"买股票的闲人","avatar":"https://static.tigerbbs.com/0e114ef410fea8b4794f5b135f43a742","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body>维立志博机会点：临床数据背书+TEC赛道的稀缺性，这两个应该够用了</body></html>","htmlText":"<html><head></head><body>维立志博机会点：临床数据背书+TEC赛道的稀缺性，这两个应该够用了</body></html>","text":"维立志博机会点：临床数据背书+TEC赛道的稀缺性，这两个应该够用了","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/452941295161656","repostId":0,"isVote":1,"tweetType":1,"viewCount":420,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["91000","09887"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":60,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}